These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 2174432

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Oxidized aldose reductase: in vivo factor not in vitro artifact.
    Grimshaw CE, Lai CJ.
    Arch Biochem Biophys; 1996 Mar 01; 327(1):89-97. PubMed ID: 8615700
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activated and unactivated forms of human erythrocyte aldose reductase.
    Srivastava SK, Hair GA, Das B.
    Proc Natl Acad Sci U S A; 1985 Nov 01; 82(21):7222-6. PubMed ID: 3933003
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Activation of aldose reductase from human tissues.
    Das B, Srivastava SK.
    Diabetes; 1985 Nov 01; 34(11):1145-51. PubMed ID: 3930326
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Aldose reductase-catalyzed reduction of acrolein: implications in cyclophosphamide toxicity.
    Kolb NS, Hunsaker LA, Vander Jagt DL.
    Mol Pharmacol; 1994 Apr 01; 45(4):797-801. PubMed ID: 8183257
    [Abstract] [Full Text] [Related]

  • 11. Inhibition kinetics of human kidney aldose and aldehyde reductases by aldose reductase inhibitors.
    Bhatnagar A, Liu SQ, Das B, Ansari NH, Srivastava SK.
    Biochem Pharmacol; 1990 Mar 15; 39(6):1115-24. PubMed ID: 2157439
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase.
    Nakano T, Petrash JM.
    Biochemistry; 1996 Aug 27; 35(34):11196-202. PubMed ID: 8780524
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Involvement of sulfhydryl residues in aldose reductase-inhibitor interaction.
    Bhatnagar A, Liu S, Das B, Srivastava SK.
    Mol Pharmacol; 1989 Dec 27; 36(6):825-30. PubMed ID: 2513474
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of aldose reductase from human retina.
    Poulsom R.
    Curr Eye Res; 1987 Mar 27; 6(3):427-32. PubMed ID: 3107906
    [Abstract] [Full Text] [Related]

  • 17. Activation of human erythrocyte, brain, aorta, muscle, and ocular tissue aldose reductase.
    Srivastava SK, Ansari NH, Hair GA, Awasthi S, Das B.
    Metabolism; 1986 Apr 27; 35(4 Suppl 1):114-8. PubMed ID: 3083202
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Isolation of a non-covalent aldose reductase-nucleotide-inhibitor complex.
    Sugiyama K, Chen Z, Lee YS, Kador PF.
    Biochem Pharmacol; 2000 Feb 15; 59(4):329-36. PubMed ID: 10644040
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.